Group 1 - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index dropped by 1.57%. The morning trading volume in Hong Kong stocks was HKD 148.2 billion [1] - The Hang Seng Biotechnology Index rose by 1.77%, with notable gains from MicroPort Medical (00853) up 9.7%, MicroPort NeuroScience (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1] - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% after announcing the construction of a modular biomanufacturing facility in Singapore [1] Group 2 - Mindray Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure the MicroPort cardiac rhythm management business, enhancing its product pipeline [2] - Insurance stocks continued to rise, with New China Life Insurance (01336) up 4.47% and China Life Insurance (02628) increasing by 1.5% [3] Group 3 - 361 Degrees (01361) rose by 6.5%, with the company showing steady revenue growth, and institutions expect strong revenue growth for the full year [4] - Dreamscape (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a long-term strategic partner [5] Group 4 - GAC Group-B (01167) surged over 20% as a concerted action party increased its holdings by over 60,000 shares, raising its stake to 25.36% [6] - Semiconductor stocks collectively declined, with Hua Hong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74% [6]

Market Overview - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index decreased by 1.57%. The early trading volume in Hong Kong stocks was HKD 148.2 billion [1]. Biotechnology Sector - The Hang Seng Biotechnology Index rose by 1.77%. Notable gainers included MicroPort Medical (00853) up 9.7%, MicroPort NeuroTech (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1]. - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% following the announcement of the construction of a modular biologics manufacturing facility in Singapore [1]. - Fosun Pharma (02196) gained over 5% after acquiring exclusive rights for the innovative Alzheimer's drug AR1001 [1]. - HeartCare Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure MicroPort's cardiac management business, enhancing its product pipeline [1]. Insurance Sector - Insurance stocks continued their upward trend, with New China Life Insurance (01336) rising by 4.47% to reach a new high, and China Life Insurance (02628) increasing by 1.5% [2]. Consumer Sector - 361 Degrees (01361) rose by 6.5%, with institutions expecting strong revenue growth for the full year [3]. - Dreamland (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a strategic shareholder from the upstream development sector [4]. Semiconductor Sector - Gako Technology-B (01167) surged over 20% as a concerted action party increased its stake by over 60,000 shares, raising its total holding to 25.36% [5]. - Semiconductor stocks collectively declined, with Huahong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74%. Nvidia's order for 300,000 H20 chips and Morgan Stanley's comments on the potential impact of the 520 unlock on local industry sentiment contributed to this decline [5].

本文源自：智通财经网 消息面上，加科思今早公布，公司董事会已获公司一致行动人士成员告知，于2025年7月24日至7月29 日，彼等已于公开市场按7.16港元的平均每股价格继续买入合计6.09万股公司股份。(紧随此次持股增加 之后，截至该公告日期，该一致行动人士成员近期合计买入115.53万股，一致行动人士共持有公司2.01 亿股股份，约占公司已发行股份总数的25.36%。 智通财经获悉，加科思-B(01167)涨超12%，截至发稿，涨11.94%，报8.72港元，成交额6594.94万港 元。 公告指出，上述一致行动人士成员表示对公司的整体发展前景、增长潜力及其股份的长期投资价值充满 信心。在遵守适用法律及监管规定的前提下，并不排除其可能适时进一步增持公司股份。 ...

消息面上，加科思今早公布，公司董事会已获公司一致行动人士成员告知，于2025年7月24日至7月29 日，彼等已于公开市场按7.16港元的平均每股价格继续买入合计6.09万股公司股份。(紧随此次持股增加 之后，截至该公告日期，该一致行动人士成员近期合计买入115.53万股，一致行动人士共持有公司2.01 亿股股份，约占公司已发行股份总数的25.36%。 公告指出，上述一致行动人士成员表示对公司的整体发展前景、增长潜力及其股份的长期投资价值充满 信心。在遵守适用法律及监管规定的前提下，并不排除其可能适时进一步增持公司股份。 加科思-B(01167)涨超12%，截至发稿，涨11.94%，报8.72港元，成交额6594.94万港元。 ...

公告指出，上述一致行动人士成员表示对公司的整体发展前景、增长潜力及其股份的长期投资价值充满 信心。在遵守适用法律及监管规定的前提下，并不排除其可能适时进一步增持公司股份。 消息面上，加科思今早公布，公司董事会已获公司一致行动人士成员告知，于2025年7月24日至7月29 日，彼等已于公开市场按7.16港元的平均每股价格继续买入合计6.09万股公司股份。(紧随此次持股增加 之后，截至该公告日期，该一致行动人士成员近期合计买入115.53万股，一致行动人士共持有公司2.01 亿股股份，约占公司已发行股份总数的25.36%。 智通财经APP获悉，加科思-B(01167)涨超12%，截至发稿，涨11.94%，报8.72港元，成交额6594.94万港 元。 ...

本文源自：金融界AI电报 7月30日早间，加科思在港交所公告，董事会已获公司一致行动人士成员告知，于2025年7月24日至7月 29日，彼等已于公开市场按7.16港元的平均每股价格继续买入合计60,900股公司股份。紧随此次持股增 加之后，截至本公告日期，该一致行动人士成员近期合计买入1,155,300股，一致行动人士共持有公司 200,755,285股股份，约占公司已发行股份总数的25.36%。上述一致行动人士成员表示对公司的整体发 展前景、增长潜力及其股份的长期投资价值充满信心。在遵守适用法律及监管规定的前提下，并不排除 其可能适时进一步增持公司股份。 ...

Group 1 - The company, 加科思-B (01167), announced that its board has been informed by members of its concert party about their continued purchase of shares in the open market at an average price of 7.16 HKD per share from July 24 to July 29, 2025 [1] - Following this increase in holdings, the concert party members have collectively purchased a total of 1.1553 million shares recently, bringing their total holdings to 201 million shares, which represents approximately 25.36% of the company's total issued shares [1]

Core Insights - The company, 加科思-B (01167), announced that its board has been informed by members of its concert party about their recent share purchases in the open market at an average price of HKD 7.16 per share [1] - Following this increase in holdings, the concert party members have collectively purchased a total of 1.1553 million shares recently, bringing their total holdings to 201 million shares, which represents approximately 25.36% of the company's total issued shares [1] Summary by Categories - **Share Purchase Activity** - The concert party members bought a total of 60,900 shares between July 24 and July 29, 2025, at an average price of HKD 7.16 per share [1] - The total recent purchases by the concert party amount to 1.1553 million shares [1] - **Ownership Structure** - The concert party now holds a total of 201 million shares, accounting for about 25.36% of the company's total issued shares [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：1167） 自願公告 一致行動人士進一步增持股份 本公告由加科思藥業集團有限公司（「本公司」或「加科思」，連同其附屬公司，統稱「本集 團」）自願刊發，以告知本公司股東及潛在投資者有關本公司一致行動人士（「一致行動人士」） 權益變動的情況。 本公司董事會（「董事會」）已獲公司一致行動人士成員告知，於2025年7月24日至7月29日， 彼等已於公開市場按7.16港元的平均每股價格繼續買入合計60,900股本公司股份（「股份」）。 緊隨此次持股增加之後，截至本公告日期，該一致行動人士成員近期合計買入1,155,300股， 一致行動人士共持有本公司200,755,285股股份，約佔本公司已發行股份總數的25.36%。 上述一致行動人士成員表示對本公司的整體發展前景、增長潛力及其股份的長期投資價 值充滿信心。在遵守適用法律及監管規定的前提 ...

Core Viewpoint - On July 28, 10 Hong Kong-listed companies conducted share buybacks, totaling 12.86 million shares and an amount of 10.74 million HKD [1][2] Group 1: Buyback Details - China Eastern Airlines repurchased 2.5 million shares for 7.50 million HKD, with a highest price of 3.030 HKD and a lowest price of 2.970 HKD, accumulating a total buyback amount of 613.45 million HKD for the year [1][2] - Carrot repurchased 160,000 shares for 816,000 HKD, with a highest price of 5.250 HKD and a lowest price of 5.080 HKD, accumulating a total buyback amount of 7.50 million HKD for the year [1][2] - Miniso repurchased 15,000 shares for 557,900 HKD, with a highest price of 37.200 HKD and a lowest price of 37.150 HKD, accumulating a total buyback amount of 313.34 million HKD for the year [1][2] Group 2: Buyback Rankings - The highest buyback amount on July 28 was from China Eastern Airlines at 7.50 million HKD, followed by Carrot at 816,000 HKD, and Miniso among others [1][2] - In terms of buyback quantity, Ying Group had the highest with 9.20 million shares, followed by China Eastern Airlines with 2.5 million shares and Maple Leaf Education with 428,000 shares [1][2]